Malignant hyperthermia (MH) is a pharmacogenetic disease of humans and various animal species that predisposes to a life-threatening, anesthetic agent-induced syndrome. MH is thought to be a consequence of abnormal, sustained increases in my-oplasmic Ca and sarcoplasmic reticulum (SR) membranes from MH muscle have been shown to have a Ca release channel defect. In the present study we have tested a hypothesis that the abnormal Ca release mechanism in MH can be expressed when Ca is loaded in the presence of pyrophosphate. SR membrane vesicles isolated from normal and MH pig muscle were loaded with Ca in the presence and absence of pyro-phosphate until Ca-induced Ca release occurred. Under both circumstances the threshold amount of Ca ...
Background: Until recently, the mechanism for the malignant hyperthermia crisis has been attributed ...
Total calcium content of both human and porcine MHS skeletal muscle is significantly less than norma...
SummaryContentMalignant hyperthermia (MH) is a potentially lethal pharmacogenetic disorder that affe...
Malignant hyperthermia (MH) is a pharmacogenetic disease of humans and various animal species that p...
Previous studies have demonstrated a defect associated with the calcium release mechanism of sarcopl...
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder of skeletal muscle that ...
In malignant hyperthermia (MH), mutations in RyR1 underlie direct activation of the channel by volat...
Malignant hyperthermia (MH) is a potentially fatal, inherited skeletal muscle disorder in humans and...
Single sarcoplasmic reticulum (SR) Ca2+ release channels were reconstituted from normal and malignan...
AbstractThe sarcoplasmic reticulum (SR) Ca2+ release channel (RyR1) from malignant hyperthermia-susc...
AbstractCalcium-induced calcium release and halothane-induced calcium release from pig sarcoplasmic ...
Malignant hyperthermia (MH), an inherited neuromuscular disease triggered by halogenated inhalationa...
Inward Ca transport and spontaneous Ca release activities were compared among sarcoplasmic reticul...
Malignant hyperthermia (MH), an inherited neuromuscular disease triggered by halogenated inhalationa...
Malignant hyperthermia (MH) is a potentially lethal pharmacogenetic disorder. Numerous mutations of ...
Background: Until recently, the mechanism for the malignant hyperthermia crisis has been attributed ...
Total calcium content of both human and porcine MHS skeletal muscle is significantly less than norma...
SummaryContentMalignant hyperthermia (MH) is a potentially lethal pharmacogenetic disorder that affe...
Malignant hyperthermia (MH) is a pharmacogenetic disease of humans and various animal species that p...
Previous studies have demonstrated a defect associated with the calcium release mechanism of sarcopl...
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disorder of skeletal muscle that ...
In malignant hyperthermia (MH), mutations in RyR1 underlie direct activation of the channel by volat...
Malignant hyperthermia (MH) is a potentially fatal, inherited skeletal muscle disorder in humans and...
Single sarcoplasmic reticulum (SR) Ca2+ release channels were reconstituted from normal and malignan...
AbstractThe sarcoplasmic reticulum (SR) Ca2+ release channel (RyR1) from malignant hyperthermia-susc...
AbstractCalcium-induced calcium release and halothane-induced calcium release from pig sarcoplasmic ...
Malignant hyperthermia (MH), an inherited neuromuscular disease triggered by halogenated inhalationa...
Inward Ca transport and spontaneous Ca release activities were compared among sarcoplasmic reticul...
Malignant hyperthermia (MH), an inherited neuromuscular disease triggered by halogenated inhalationa...
Malignant hyperthermia (MH) is a potentially lethal pharmacogenetic disorder. Numerous mutations of ...
Background: Until recently, the mechanism for the malignant hyperthermia crisis has been attributed ...
Total calcium content of both human and porcine MHS skeletal muscle is significantly less than norma...
SummaryContentMalignant hyperthermia (MH) is a potentially lethal pharmacogenetic disorder that affe...